Integrative medicine in the era of cancer immunotherapy: Challenges and opportunities

Genova, 2017, Releasing the brake: safety profile of immune check-point inhibitors in non-small cell lung cancer, Expert Opin Drug Saf, 16, 573, 10.1080/14740338.2017.1313228 Smyth, 2016, Combination cancer immunotherapies tailored to the tumour microenvironment, Nat Rev Clin Oncol, 13, 143, 10.1038/nrclinonc.2015.209 Kroschinsky, 2017, New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management, Crit Care, 21, 89, 10.1186/s13054-017-1678-1 Tang, 2008, Traditional Chinese medicine, Lancet, 372, 1938, 10.1016/S0140-6736(08)61354-9 Hu, 2016, Advances in synergistic combinations of Chinese herbal medicine for the treatment of cancer, Curr Cancer Drug Targets, 16, 346, 10.2174/1568009616666151207105851 Qi, 2015, The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer, Biosci Trends, 9, 16, 10.5582/bst.2015.01019 Zheng, 2018, Network pharmacology to unveil the biological basis of health-strengthening herbal medicine in cancer treatment, Cancers, 10, 461, 10.3390/cancers10110461 Jeong, 2010, Bojungikki-tang for cancer-related fatigue: a pilot randomized clinical trial, Integr Cancer Ther, 9, 331, 10.1177/1534735410383170 Ishikawa, 2017, Efficacy of Juzentaihoto for tumor immunotherapy in B16 melanoma metastasis model, Evid Based Complement Alternat Med, 2017, 1, 10.1155/2017/6054706 Ling CQ. The role and status of traditional Chinese medicine in the prevention and treatment of cancer. Zhongguo Zhong Xi Yi Jie He Za Zhi 2007; 27(5): 390–1 [Chinese]. So, 2019, Chinese medicine in cancer treatment: how is it practised in the East and the West?, Clin Oncol, 31, 578, 10.1016/j.clon.2019.05.016 Kennedy, 2020, A review of cancer immunotherapy toxicity, CA Cancer J Clin, 70, 86, 10.3322/caac.21596 Chen, 2013, Oncology meets immunology: the cancer-immunity cycle, Immunity, 39, 1, 10.1016/j.immuni.2013.07.012 Abril-Rodriguez, 2017, Snapshot: immune checkpoint inhibitors, Cancer Cell, 31, 848, 10.1016/j.ccell.2017.05.010 Champiat, 2016, Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper, Ann Oncol, 27, 559, 10.1093/annonc/mdv623 Davies, 2017, Safety of checkpoint inhibitors for cancer treatment: strategies for patient monitoring and management of immune-mediated adverse events, Immunotargets Ther, 6, 51, 10.2147/ITT.S141577 Eggermont, 2016, Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy, N Engl J Med, 375, 1845, 10.1056/NEJMoa1611299 Moslehi, 2018, Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis, Lancet, 391, 933, 10.1016/S0140-6736(18)30533-6 Longo, 2018, Immune-related adverse events associated with immune checkpoint blockade, N Engl J Med, 378, 158, 10.1056/NEJMra1703481 Frey, 2019, Cytokine release syndrome with chimeric antigen receptor T cell therapy, Biol Blood Marrow Transplant, 25, e123, 10.1016/j.bbmt.2018.12.756 Liao, 2017, Traditional Chinese medicine as adjunctive therapy improves the long-term survival of lung cancer patients, J Cancer Res Clin Oncol, 143, 2425, 10.1007/s00432-017-2491-6 Lam, 2017, A pilot randomized controlled trial of acupuncture at the Si Guan Xue for cancer pain, BMC Complement Altern Med, 17, 335, 10.1186/s12906-017-1838-5 Zhao, 2020, Comparable effects of Jiedu granule, a compound Chinese herbal medicine, and sorafenib for advanced hepatocellular carcinoma: a prospective multicenter cohort study, J Integr Med, 18, 319, 10.1016/j.joim.2020.05.003 Wang, 2020, Positive role of Chinese herbal medicine in cancer immune regulation, Am J Chin Med, 48, 1577, 10.1142/S0192415X20500780 Wong, 2015, Recent advances in ginseng as cancer therapeutics: a functional and mechanistic overview, Nat Prod Rep, 32, 256, 10.1039/C4NP00080C He, 2017, Ginseng (Panax ginseng Meyer) oligopeptides regulate innate and adaptive immune responses in mice via increased macrophage phagocytosis capacity, NK cell activity and Th cells secretion, Food Funct, 8, 3523, 10.1039/C7FO00957G Jiang, 2017, Ginsenoside Rg3 attenuates cisplatin resistance in lung cancer by downregulating PD-L1 and resuming immune, Biomed Pharmacother, 96, 378, 10.1016/j.biopha.2017.09.129 Yim, 2020, Inhibition of programmed death receptor-1/programmed death ligand-1 interactions by ginsenoside metabolites, Molecules, 25, 2068, 10.3390/molecules25092068 Taixiang, 2005, Chinese medical herbs for chemotherapy side effects in colorectal cancer patients, Cochrane Database Syst Rev, 1, Cd004540 Chen, 2019, Astragaloside III enhances anti-tumor response of NK cells by elevating NKG2D and IFN-γ, Front Pharmacol, 10, 898, 10.3389/fphar.2019.00898 Wang, 2018, An update on Chinese herbal medicines as adjuvant treatment of anticancer therapeutics, Biosci Trends, 12, 220, 10.5582/bst.2018.01144 Jia, 2020, Using traditional Chinese medicine to treat hepatocellular carcinoma by targeting tumor immunity, Evid Based Complement Alternat Med, 2020, 1 Wang, 2009, Melittin, a major component of bee venom, sensitizes human hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating CaMKII-TAK1-JNK/p38 and inhibiting IκBα kinase NFκB, J Biol Chem, 284, 3804, 10.1074/jbc.M807191200 Lim, 2018, Traditional Chinese medicine: herb-drug interactions with aspirin, Singapore Med J, 59, 230, 10.11622/smedj.2018051 Yeung, 2018, Herb-drug interactions in cancer care, Oncology, 32, 516 Ma, 2013, Traditional Chinese medicine and immune regulation, Clin Rev Allergy Immunol, 44, 229, 10.1007/s12016-012-8332-0